Evidence map›Paper›PMID 34283907›Full record

ArticleArchives of endocrinology and metabolism2021

Polymorphism (-499C/G) in

Elnaz Faramarzi, Younes Aftabi, Khalil Ansarin, Mohammad Hossein Somi, Neda Gilani, Ensiyeh Seyedrezazadeh

Open access · diamondAbstract read
In one paragraph

Article in Archives of endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elnaz FaramarziLiver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Younes AftabiTuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Khalil AnsarinTuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammad Hossein SomiLiver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Neda GilaniDepartment of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
Ensiyeh SeyedrezazadehTuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, e.s.rezazadeh@tbzmed.ac.ir.
Tabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveGlobally developing metabolic syndrome (MetS) prevalence as a major health problem can be related to multiple factors of genetic and environmental. Dimethylaminohydrolase 2 (DDAH2) is the main enzyme implicated in the cardiovascular system, which regulates the nitric oxide pathway. This study investigated the association of

methodsThe occurrence of SNP rs805305 in the

resultsThe G allele and GC genotype were significantly associated with a reduced risk of MetS (

conclusionThe -499C/G polymorphism of

Indexed as

Metabolic SyndromeAmidohydrolasesCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMalePolymorphism, GeneticPolymorphism, Single NucleotidePromoter Regions, GeneticProtective FactorsAmidohydrolasesdimethylargininasecohort studyDDAH2metabolic syndromepolymorphismrs805305

Identifiers

PMID34283907
PMCPMC10522192
OpenAlexW3186808798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.